A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
Clinical trial NCT03104413 · COMPLETED
Trial details
- NCT number
- NCT03104413
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2020-11-30
- Enrollment
- 618
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.